Showing results (121-130 of 463) with videos related to
Sort By:
Pageof 47
Cell Cycle (Georgetown, Tex.)|October 4, 2007
Hyperspectral image analysis of live cells in various cell cycle stagesDavid T Dicker, Jeremy M Lerner, Wafik S El-DeiryOncotarget|July 2, 2024
Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers and overcomes cancer stemness, trifluridine-induced angiogenesis, ERK1/2 and STAT3 signaling regardless of KRAS or BRAF mutational statusJun Zhang, Lanlan Zhou, Shuai Zhao, et al.Biochemical and Biophysical Research Communications|February 25, 1998
Identification of a novel AP-2 consensus DNA binding siteM S Gee, C J Sarkisian, W S el-DeiryCurrent Colorectal Cancer Reports|August 13, 2016
Circulating Tumor Cells Versus Circulating Tumor DNA in Colorectal Cancer: Pros and ConsCarlyn Rose C Tan, Lanlan Zhou, Wafik S El-DeiryThe Journal of Biological Chemistry|January 14, 2016
The Deubiquitinase Inhibitor PR-619 Sensitizes Normal Human Fibroblasts to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-mediated Cell DeathRoslyn N Crowder, David T Dicker, Wafik S El-DeiryOncogene|August 11, 2001
Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivoT F Burns, E J Bernhard, W S El-DeiryProceedings of the National Academy of Sciences of the United States of America|December 1, 1984
Molecular mechanisms of manganese mutagenesisW S El-Deiry, K M Downey, A G SoMicropublication Biology|February 12, 2024
miR-6883 downregulates HIF1α in colorectal and breast cancer cellsNicole A Jensen-Velez, Lindsey Carlsen, Wafik S El-DeiryOncotarget|October 6, 2021
A high-throughput customized cytokinome screen of colon cancer cell responses to small-molecule oncology drugsKelsey E Huntington, Anna Louie, Lanlan Zhou, et al.Cell Cycle (Georgetown, Tex.)|April 3, 2008
CARPs enhance p53 turnover by degrading 14-3-3sigma and stabilizing MDM2Wensheng Yang, David T Dicker, Jiandong Chen, et al.Pageof 47